Segment Information (Tables)

9 Months Ended

Mar. 31, 2021

Summary Of Revenue By Segment And Reconciling Items


	Three Months Ended ‎March 31,				Nine Months Ended ‎March 31,
	2021		2020		2021		2020
Net revenue by segment
Total Sleep and Respiratory Care	$	674,931	$	679,895	$	2,042,909	$	1,923,513

Software as a Service		93,836		89,560		277,813		265,258
Deferred revenue fair value adjustment ⁽¹⁾		-		-		-		(2,102)
Total Software as a Service		93,836		89,560		277,813		263,156
Total	$	768,767	$	769,455	$	2,320,722	$	2,186,669

Depreciation and amortization by segment
Sleep and Respiratory Care	$	13,589	$	14,134	$	39,979	$	43,012
Software as a Service		1,491		1,025		3,599		2,844
Amortization of acquired intangible assets and corporate assets		24,908		24,105		76,456		70,485
Total	$	39,988	$	39,264	$	120,034	$	116,341

Net operating profit by segment ⁽²⁾
Sleep and Respiratory Care ⁽²⁾	$	253,693	$	250,209	$	763,534	$	678,468
Software as a Service ⁽²⁾		23,052		18,738		70,929		63,874
Total	$	276,745	$	268,947	$	834,463	$	742,342

Reconciling items
Corporate costs	$	34,950	$	31,039	$	106,307	$	94,933
Amortization of acquired intangible assets		18,369		20,408		57,443		59,495
Restructuring expenses		-		-		8,673		-
Litigation settlement expenses		-		-		-		(600)
Deferred revenue fair value adjustment ⁽¹⁾		-		-		-		2,102
Interest expense (income), net		5,823		9,852		18,341		30,414
Loss attributable to equity method investments		4,969		5,295		9,895		19,082
Other, net		(5,371)		10,698		(10,647)		15,922
Income before income taxes	$	218,005	$	191,655	$	644,451	$	520,994

(1) The deferred revenue fair value adjustment is a purchase price accounting adjustment related to MatrixCare which was acquired on November 13, 2018.

(2)During the three and nine months ended March 31, 2021, we recorded $0.0 million and $2.8 million of impairment for our operating lease right-of-use asset, respectively. The impairment related to leases for office space and was recorded within net operating profit. The impairment for the nine months ended March 31, 2021 attributable to Sleep and Respiratory Care was $1.6 million and $1.2 million for SaaS